Prevention: Given the association of androgen receptor (AR) signaling with bladder carcinogenesis and the likely role of the AR in the substantial male sex bias in bladder cancer, anti-androgen monotherapies may have a future role in bladder cancer prevention. This evidence concerns the gene AR and urinary bladder cancer.